EXTENDICARE INC (EXE.CA) Stock Overview
Canada - TSX:EXE - CA30224T8639 - Common Stock
EXE.CA Key Statistics, Chart & Performance
The current stock price of EXE.CA is 13.28 CAD. In the past month the price decreased by -1.48%. In the past year, price increased by 41.28%.
EXE.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CSH-UN.CA | CHARTWELL RETIREMENT RESIDEN | 96 | 5.83B | ||
| SIA.CA | SIENNA SENIOR LIVING INC | 45.58 | 1.69B | ||
| DR.CA | MEDICAL FACILITIES CORP | 8.54 | 275.06M |
Related stock screener links
About EXE.CA
Company Profile
Extendicare, Inc. engages in the provision of nursing care, home health care, retirement living, and management and consulting services. The company is headquartered in Markham, Ontario. The firm operates under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. The firm operates a network of approximately 99 long-term care homes (59 owned, 40 under management contracts), delivers approximately 11.2 million hours of home health care services annually, and provides group purchasing services to third parties representing approximately 148,200 beds across Canada. Its segments include Long-term Care, Home Health Care, and Managed Services. The firm provides home healthcare services through ParaMed, which is engaged in providing complex nursing care, occupational, physical and speech therapy and assistance with daily activities to accommodate clients of all ages living at home. Its Managed Services segment includes its management contracts and consulting and other services, and group purchasing services.
Company Info
EXTENDICARE INC
3000 Steeles Avenue East, Suite 400
Markham ONTARIO L3R 9W2 CA
CEO: Michael R. Guerriere
Employees: 22000
Phone: 19054704000
EXTENDICARE INC / EXE.CA FAQ
What is the stock price of EXTENDICARE INC today?
The current stock price of EXE.CA is 13.28 CAD. The price increased by 0.91% in the last trading session.
What is the ticker symbol for EXTENDICARE INC stock?
The exchange symbol of EXTENDICARE INC is EXE and it is listed on the Toronto Stock Exchange exchange.
On which exchange is EXE.CA stock listed?
EXE.CA stock is listed on the Toronto Stock Exchange exchange.
What is the price forecast or stock price prediction for EXTENDICARE INC stock?
11 analysts have analysed EXE.CA and the average price target is 16.63 CAD. This implies a price increase of 25.2% is expected in the next year compared to the current price of 13.28. Check the EXTENDICARE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is EXTENDICARE INC worth?
EXTENDICARE INC (EXE.CA) has a market capitalization of 1.11B CAD. This makes EXE.CA a Small Cap stock.
How many employees does EXTENDICARE INC have?
EXTENDICARE INC (EXE.CA) currently has 22000 employees.
What are the support and resistance levels for EXTENDICARE INC (EXE.CA) stock?
EXTENDICARE INC (EXE.CA) has a support level at 13.23 and a resistance level at 14.55. Check the full technical report for a detailed analysis of EXE.CA support and resistance levels.
Is EXTENDICARE INC (EXE.CA) expected to grow?
The Revenue of EXTENDICARE INC (EXE.CA) is expected to grow by 11.08% in the next year. Check the estimates tab for more information on the EXE.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy EXTENDICARE INC (EXE.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of EXE.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of EXE.CA, evaluating the profitability, health, valuation and growth aspects
- EXTENDICARE INC (EXE.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- EXTENDICARE INC (EXE.CA) Sales and EPS estimates to see what analysts future expectations are.
- EXTENDICARE INC (EXE.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- EXTENDICARE INC (EXE.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- EXTENDICARE INC (EXE.CA) Stock Chart to make your own analysis
- EXTENDICARE INC (EXE.CA) Latest news and press-releases to stay up to date.
Does EXTENDICARE INC (EXE.CA) stock pay dividends?
EXTENDICARE INC (EXE.CA) has a dividend yield of 3.83%. The yearly dividend amount is currently 0.48. Check the full fundamental report for a detailed analysis of EXE.CA dividend history, reliability and sustainability.
When does EXTENDICARE INC (EXE.CA) report earnings?
EXTENDICARE INC (EXE.CA) will report earnings on 2025-11-10.
What is the Price/Earnings (PE) ratio of EXTENDICARE INC (EXE.CA)?
The PE ratio for EXTENDICARE INC (EXE.CA) is 14.28. This is based on the reported non-GAAP earnings per share of 0.93 and the current share price of 13.28 CAD. Check the full fundamental report for a full analysis of the valuation metrics for EXE.CA.
EXE.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to EXE.CA. When comparing the yearly performance of all stocks, EXE.CA turns out to be only a medium performer in the overall market: it outperformed 64.68% of all stocks.
EXE.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to EXE.CA. While EXE.CA has a great profitability rating, there are some minor concerns on its financial health.
EXE.CA Financial Highlights
Over the last trailing twelve months EXE.CA reported a non-GAAP Earnings per Share(EPS) of 0.93. The EPS increased by 46.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.51% | ||
| ROA | 10.69% | ||
| ROE | 55.86% | ||
| Debt/Equity | 1.79 |
EXE.CA Forecast & Estimates
11 analysts have analysed EXE.CA and the average price target is 16.63 CAD. This implies a price increase of 25.2% is expected in the next year compared to the current price of 13.28.
For the next year, analysts expect an EPS growth of 25% and a revenue growth 11.08% for EXE.CA